Medicare Enrolled
Dr. Christofer Buatti, D.O.
Internal Medicine · Auburn Hills, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Buatti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Buatti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Buatti
Dr. Christofer Buatti is an internal medicine specialist in Auburn Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Buatti performed 9,180 Medicare services across 1,955 unique beneficiaries.
Between the years covered by Open Payments, Dr. Buatti received a total of $243,468 from 59 pharmaceutical and/or device companies across 1992 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Buatti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in MI
$243,468 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,180
Medicare services
Top 1% in MI for internal medicine
1,955
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~459 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, tildrakizumab, 1 mg | 3,900 | $110 | $180 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,027 | $5 | $9 |
| Ultrasound guidance for radiation therapy field placement Use of ultrasound imaging to help position radiation therapy fields accurately during treatment. |
544 | $145 | $230 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
467 | $63 | $118 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
453 | $218 | $344 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
448 | $91 | $166 |
| Superficial or low voltage radiation treatment A radiation therapy procedure that delivers radiation to the surface of the body or uses low voltage energy. This treatment targets areas close to the skin. |
439 | $33 | $68 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
286 | $83 | $149 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
272 | $37 | $88 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
229 | $128 | $222 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
178 | $66 | $132 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
97 | $77 | $147 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
94 | $1 | $1 |
| Radiation treatment management, 5 sessions Oversight and management of a radiation therapy course consisting of five treatment sessions. |
78 | $155 | $251 |
| Destruction of skin growth, 15 or more growths | 77 | $105 | $173 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
59 | $41 | $65 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
56 | $10 | $18 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $38 | $74 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $108 | $218 |
| Continuing radiation therapy consultation per week A weekly consultation to review and manage ongoing radiation therapy treatment. |
49 | $71 | $114 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
44 | $34 | $75 |
| Calculation of radiation therapy dose | 40 | $54 | $85 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
38 | $515 | $1,137 |
| Injection into skin growths, more than 7 A procedure involving the injection of medication into more than seven skin growths. |
26 | $46 | $92 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
26 | $191 | $563 |
| Skin growth removal and lab exam, 1-5 blocks A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination. |
26 | $506 | $837 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
20 | $221 | $518 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
20 | $226 | $805 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 18 | $340 | $693 |
| Design and construction of simple radiation treatment device This code covers the design and construction of a simple radiation treatment device. It does not specify the clinical purpose or condition being treated. |
18 | $31 | $63 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
16 | $94 | $165 |
| Simple radiation therapy planning This procedure involves the initial planning phase for radiation therapy treatment. It includes the setup and configuration required to prepare for delivering radiation to a specific area. |
14 | $58 | $92 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
11 | $55 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$243,468
Total received (2018-2024)
Avg $34,781/year across 7 years
Top 1% in MI for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,992
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$203,423 (83.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,183 (8.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$18,863 (7.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$37,599
2023
$60,927
2022
$27,013
2021
$12,392
2020
$18,392
2019
$46,271
2018
$40,874
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SUN PHARMACEUTICAL INDUSTRIES INC.
$21,332
Incyte Corporation
$10,004
GENZYME CORPORATION
$2,989
Dermavant Sciences, Inc.
$699
ABBVIE INC.
$416
UCB, Inc.
$355
Janssen Biotech, Inc.
$261
Boehringer Ingelheim Pharmaceuticals, Inc.
$232
Novartis Pharmaceuticals Corporation
$209
E.R. Squibb & Sons, L.L.C.
$174
Arcutis Biotherapeutics, Inc.
$135
Amgen Inc.
$135
PFIZER INC.
$107
Regeneron Healthcare Solutions, Inc.
$98
Ortho Dermatologics, a division of Bausch Health US, LLC
$94
Lilly USA, LLC
$85
Journey Medical Corporation
$66
Kerecis Limited
$59
LEO Pharma Inc.
$41
Organogenesis Inc.
$35
Galderma Laboratories, L.P.
$28
Verrica Pharmaceuticals Inc.
$25
Genentech USA, Inc.
$20
Top 3 companies account for 91.3% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$48,451
Sun Pharmaceutical Industries Inc.
$42,972
Incyte Corporation
$38,706
SUN PHARMACEUTICAL INDUSTRIES INC.
$22,138
Amgen Inc.
$19,188
Almirall LLC
$11,148
GENZYME CORPORATION
$7,423
E.R. Squibb & Sons, L.L.C.
$7,241
Novartis Pharmaceuticals Corporation
$6,723
Promius Pharma LLC
$6,312
Taro Pharmaceuticals USA, Inc.
$5,019
Ortho Dermatologics, a division of Bausch Health US, LLC
$3,807
Dermavant Sciences, Inc.
$3,551
PFIZER INC.
$3,235
UCB, Inc.
$2,173
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,771
Janssen Biotech, Inc.
$1,664
Galderma Laboratories, L.P.
$1,259
Regeneron Healthcare Solutions, Inc.
$913
Journey Medical Corporation
$843
Encore Dermatology Inc.
$832
ABBVIE INC.
$794
EPI Health, LLC
$773
AbbVie Inc.
$742
VYNE Pharmaceuticals Inc.
$673
Biofrontera Inc.
$532
Medimetriks Pharmaceuticals, Inc.
$518
AbbVie, Inc.
$517
LEO Pharma Inc.
$484
Lilly USA, LLC
$415
Arcutis Biotherapeutics, Inc.
$312
Mayne Pharma Inc.
$284
Allergan Inc.
$264
Novum Pharma, LLC
$225
Mylan Pharmaceuticals Inc.
$159
MAYNE PHARMA INC.
$133
Sandoz Inc.
$128
Janssen Scientific Affairs, LLC
$122
MAYNE PHARMA COMMERCIAL LLC
$118
Bayer HealthCare Pharmaceuticals Inc.
$116
Genentech USA, Inc.
$106
Allergan, Inc.
$100
SANOFI-AVENTIS U.S. LLC
$100
Kerecis Limited
$98
Smith+Nephew, Inc.
$84
Verrica Pharmaceuticals Inc.
$42
Sebela Pharmaceuticals Inc.
$36
Organogenesis Inc.
$35
Aclaris Therapeutics, Inc.
$34
Sensus Healthcare, Inc.
$25
Misonix Inc
$16
Mission Pharmacal Company
$16
DUSA Pharmaceuticals, Inc.
$16
DERMIRA, INC.
$15
Paratek Pharmaceuticals, Inc.
$15
NOVARTIS PHARMACEUTICALS CORPORATION
$14
Exeltis, USA Inc.
$14
Merck Sharp & Dohme Corporation
$12
Smith & Nephew, Inc.
$12
Top 3 companies account for 53.4% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALDARA · ALTRENO · AMELUZ · AMZEEQ · APEXICON E · ARAZLO · Absorica LD · Acticlate · Aczone · Alcortin A · BLU-U · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Ceracade · Cimzia · Cloderm Cream · Cordran · Cordran Tape · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EUCRISA · Eletone · Erivedge · Exelderm · FINACEA · Finacea · HALOG · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · HYRIMOZ · Humira · ILUMYA · Ilumya · Impoyz · JUBLIA · KERYDIN · Kerecis Omega3 SurgiClose · Klisyri · LIBTAYO · NAFTIN · NUZYRA · Neo-Synalar · Neo-Synalar Cream · Neosalus · OLUMIANT · OPZELURA · ORACEA · Olux · Otezla · PRAMOSONE · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SEYSARA · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Santyl · Sernivo · Sernivo Spray · Seysara · Sitavig · Sotyktu · TALTZ · TARGRETIN · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TRIANEX 0.05% · Tremfya · Trianex · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VTAMA · Veltin · Verdeso · Winlevi · XELJANZ · Xolair · Xolegel · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in MI.
Geographic Context
Internal medicine physicians within 10 mi
2,264
Per 100K population
177.9
County median income
$95,296
Nearest hospital
HAVENWYCK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Buatti is a mixed practice specialist, with above-average Medicare volume (top 1% in MI), with speaking/promotional industry engagement in the top 1% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Buatti experienced with injection, tildrakizumab, 1 mg?
Based on Medicare claims data, Dr. Buatti performed 3,900 injection, tildrakizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Buatti receive payments from pharmaceutical companies?
Yes. Dr. Buatti received a total of $243,468 from 59 companies across 1,992 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Buatti's costs compare to other internal medicine physicians in Auburn Hills?
Dr. Buatti's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Buatti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Auburn Hills
Browse internal medicine physicians in Auburn Hills ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in MI
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in MI
Which MI internal medicine physicians receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Sun Pharmaceutical Industries Inc. Payments to Doctors
See all physicians who received payments from Sun Pharmaceutical Industries Inc.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology